Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FHLC vs JDOC overlap: 63% of top holdings shared

Bottom line

How much do FHLC and JDOC overlap?

63% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 56.4% of FHLC's assets and 55.8% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.

FHLC holds far more positions (337 vs 61), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FHLCJDOC
Weight overlap (top 25)63%
Shared holdings15
Weight in shared holdings56.4%55.8%
Total positions33761
Expense ratio0.084%0.65%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings FHLC and JDOC have in common

Holding% of FHLC% of JDOCOverlap
Eli Lilly & Co13.35%7.76%7.76%
Johnson & Johnson8.93%4.82%4.82%
AbbVie Inc6.42%7.85%6.42%
UnitedHealth Group Inc5.44%5.85%5.44%
Merck & Co Inc4.66%4.82%4.66%
Thermo Fisher Scientific Inc3.09%3.73%3.09%
Abbott Laboratories2.66%3.11%2.66%
Bristol-Myers Squibb Co1.93%3.57%1.93%
CVS Health Corp1.92%2.83%1.92%
Intuitive Surgical Inc1.82%1.93%1.82%
Danaher Corp1.80%2.16%1.80%
Stryker Corp1.62%2.23%1.62%
Regeneron Pharmaceuticals Inc1.15%1.60%1.15%
Cencora Inc0.83%2.07%0.83%
Cardinal Health Inc0.78%1.51%0.78%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FHLC

  1. Amgen Inc — 3.00%
  2. Gilead Sciences Inc — 2.34%
  3. Pfizer Inc — 2.06%
  4. Vertex Pharmaceuticals Inc — 1.76%
  5. Medtronic PLC — 1.59%
  6. McKesson Corp — 1.52%
  7. Elevance Health Inc — 1.19%
  8. Cigna Group/The — 1.06%
  9. Boston Scientific Corp — 1.00%
  10. HCA Healthcare Inc — 0.91%

Only in JDOC

  1. AstraZeneca plc — 3.76%
  2. Roche Holding AG — 2.82%
  3. Novo Nordisk A/S — 2.61%
  4. GSK plc — 2.47%
  5. Argenx SE — 2.06%
  6. Edwards Lifesciences Corp. — 1.73%
  7. IQVIA Holdings, Inc. — 1.71%
  8. Teva Pharmaceutical Industries Ltd. — 1.60%
  9. Novartis AG — 1.60%
  10. Biogen, Inc. — 1.56%

Asset mix

Asset typeFHLCJDOC
Stocks99.7%99.2%
Cash & short-term funds0.2%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryFHLCJDOC
US96.5%75.2%
GB0.5%6.2%
CH0.1%4.4%
DK—4.0%
JP—2.5%
NL0.1%2.4%
IE2.2%0.4%
DE—1.9%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do FHLC and JDOC overlap?
About 63% by weight. 15 securities appear in both funds' top 25 holdings; they make up 56.4% of FHLC's assets and 55.8% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FHLC and JDOC have in common?
The largest shared holdings are Eli Lilly & Co, AbbVie Inc, UnitedHealth Group Inc, Johnson & Johnson, Merck & Co Inc.
Should I own both FHLC and JDOC?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FHLC or JDOC?
FHLC is broader, with 337 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.